Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins.
about
MicroRNA-targeted therapeutics for lung cancer treatment.Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy.miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
P2860
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aptamer-hybrid nanoparticle bi ...... lating essential oncoproteins.
@en
type
label
Aptamer-hybrid nanoparticle bi ...... lating essential oncoproteins.
@en
prefLabel
Aptamer-hybrid nanoparticle bi ...... lating essential oncoproteins.
@en
P2093
P2860
P356
P1476
Aptamer-hybrid nanoparticle bi ...... lating essential oncoproteins.
@en
P2093
Ashakumary Lakshmikuttyamma
Christina Maher
Maryna Perepelyuk
Sunday A Shoyele
P2860
P304
P356
10.2147/IJN.S110488
P407
P577
2016-07-28T00:00:00Z